Skip to content

Randomized Trial of Y Mesh vs Dual Mesh

A Prospective Randomized Trial Comparing Restorelle Y Mesh vs. Restorelle Dual Flat Mesh for Laparoscopic and Robotic-assisted Laparoscopic Sacrocolpopexy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02156687
Enrollment
59
Registered
2014-06-05
Start date
2014-04-14
Completion date
2020-04-01
Last updated
2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolapse

Brief summary

The primary objective of the proposed study is to determine the difference in suturing time when using the restorelle Y mesh versus the restorelle dual flat mesh at the time of laparoscopic and robotic-assisted laparoscopic sacrocolpopexy. Hypothesis: Suturing time when using the restorelle Y mesh will be faster than when using the restorelle dual flat mesh at the time of laparoscopic and robotic-assisted laparoscopic sacrocolpopexy.

Detailed description

Study Design: Randomized single-blind prospective clinical trial Primary Outcomes: 1. Total Suturing time for mesh placement = time from insertion of Y mesh or first flat mesh arm into pelvis to last sacral suture placed 2. Total Case time = Incision to end of closure Secondary Outcomes: Post-operative patient outcomes at 24-months * Pelvic Floor Dysfunction Inventory (PFDI-20) * Pelvic Organ Prolapse Distress Inventory (POPDI) * Colorectal Anal Distress Inventory (CRADI) * Urogenital Distress Inventory (UDI) * Objective Recurrence (POP-Q) * Subjective Recurrence (vaginal bulge) * Reported mesh erosion Study Population: Study subjects will be recruited from patients that present to the Center of Urogynecology and Pelvic Floor Disorders in the Department of Obstetrics and Gynecology at the Cleveland Clinic main campus, Hillcrest Hospital and Fairview Hospital, and their surgeries will be performed at either one of these sites. Study Procedures: Study Identification and Recruitment Potential subjects will be identified by members of the Center for Urogynecology and Pelvic Reconstructive Surgery at the Cleveland Clinic main campus and Fairview Hospital. Eligible patients that agree to participate will be provided written informed consent administered by the collaborators listed on this Investigational Research Board (IRB) proposal at Cleveland Clinic Main campus and Fairview Hospitals. Randomization All subjects will be predetermined by their surgeon to undergo either a laparoscopic or robotic assisted laparoscopic sacrocolpopexy depending upon their clinical evaluation. The participants will then be randomized to either Y mesh or dual flat mesh sacrocolpopexy according to a computer-generated randomization schedule with random block sizes with the use of the SAS statistical software package (SAS Institute, Cary, NC). Randomization will be carried out by provider. All patients will be blinded to their assignment. Office Interventions In addition to a standardized evaluation including the history and physical examination, patients will be asked to complete the Pelvic Floor Distress Inventory (PFDI-20) questionnaire at the pre-operative visit as well as the 6, 12 and 24-month postoperative visit. Completion of these questionnaire is the only additional assessment that is specific to participation in this study and is not usually included as part of the standard care of sacrocolpopexy. It should take no more than 10-15 minutes to complete the questionnaire. The study subjects will not be exposed to any additional risk by participating in this study except for the inconvenience of completing the questionnaire. Surgical Interventions Laparoscopic sacrocolpopexy will be performed using four ports: an umbilical port for the laparoscope, two ports (either 5 or 10/12 mm) in the bilateral lower quadrants, and one 5-mm port placed at the level of the umbilicus, lateral to the rectus muscle on either side for retraction. The robotic-assisted hysterectomy will be performed using the da Vinci Surgical System (Intuitive Surgical Inc., Sunnyvale, CA, USA) using five ports: a 12mm umbilical port for the laparoscopic, two 8 mm robotic ports placed 2cm inferior and 9-10cm lateral to the umbilicus bilaterally, an 8mm robotic port placed in the left axillary line at the level of the umbilicus, and a 8mm or 10/12mm accessory port either in the right upper quadrant approximately 3cm distal from the costal margin, or in the right lower quadrant, 2cm above and medial to the anterior superior iliac spine. If a supracervical hysterectomy is to be performed, it will be done in a standard fashion. A uterine manipulator will be placed inside of the uterus. The round ligaments will be transected using cautery. The fallopian tubes and ovaries will be left in situ or removed at the time of hysterectomy depending upon the preoperative decision made between the surgeon and patient. The uterine arteries and cardinal ligaments will be cauterized laparoscopically. The uterus will be amputated at the level of the internal cervical os and the endocervical canal will be cauterized. The sacrocolpopexy will also be performed and in a standard fashion. An end-to-end anastomosis (EEA) sizer will be placed in the vagina for manipulation of the apex as well as in the rectum for delineation of the rectovaginal septum. First, the presacral dissection will be performed with a longitudinal peritoneal incision over the sacral promontory and there is identification of the anterior longitudinal ligament. Dissection is then done caudally through the peritoneum and subperitoneal fat down to the level of the posterior cul-de-sac. The vagina is elevated cephalad using the EEA sizer and the peritoneum overlying the anterior vaginal apex is incised transversely, and the bladder is dissected off the anterior vagina using sharp dissection, creating a 4 to 5 cm pocket. If this plane is difficult to establish, the bladder will be filled in a retrograde fashion to find the correct dissection plane. Similarly, the peritoneum overlying the posterior vagina is incised, and dissection is then done overlying the vagina and extending into the posterior cul-de-sac, creating a 4 to 5 cm pocket. Once dissection is complete, the mesh graft is prepared. Subjects will have been randomized to either one of two mesh grafts: 1. Restorelle Y mesh * The mesh is introduced into the pelvis through one of the ports. * First, either then anterior or the posterior arm is fixed to the anterior or posterior vaginal wall using 5 delayed- absorbable (PDS) No. 2-0 sutures in an interrupted fashion, 1 to 2 cm apart from each other. * The opposing arm of the graft is then attached to either the anterior or posterior vaginal wall, depending on which arm was placed first, in a similar fashion using 5 delayed- absorbable (PDS) No. 2-0 sutures in an interrupted fashion, 1 to 2 cm apart from each other. * The stem portion of the graft is then brought to the sacral promontory and sutured to the anterior longitudinal ligament using 2 permanent (prolene) No. 0 sutures. The excess mesh is then trimmed. 2. Restorelle dual flat mesh: 2 pieces of 15 x 4 cm mesh * One mesh arm is introduced into the pelvis through one of the ports. * The arm is fixed to the anterior or posterior vaginal wall using 5 delayed- absorbable (PDS) No. 2-0 sutures in an interrupted fashion, 1 to 2 cm apart from each other. * The second mesh arm is then introduced into the pelvis through one of the ports. * The arm is fixed to either the anterior or posterior vaginal wall, depending on where the first arm was placed, using 5 delayed- absorbable (PDS) No. 2-0 sutures in an interrupted fashion, 1 to 2 cm apart from each other. * The two arms are then brought to the sacral promontory and sutured together to the anterior longitudinal ligament using 2 permanent (prolene) No. 0 sutures. The excess mesh is then trimmed. The peritoneum is then closed over the exposed graft with absorbable suture. Routine cystoscopy will also be performed in order to assess for lower urinary tract injury. A vaginal exam is performed, and an anterior and/or posterior colporrhaphy and perineorrhaphy are performed if needed. Anti-incontinence procedures may also be performed if needed. \*\*In laparoscopic cases, all suturing will be done extracorporeally while intracorporeal knot-tying technique will be performed in robot assisted laparoscopic cases.

Interventions

DEVICEY mesh

Y mesh

DEVICEDual flat mesh

Dual flat mesh

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18, who are to undergo laparoscopic or robotic laparoscopic sacrocolpopexy for pelvic organ prolapse * Other concomitant laparoscopic or prolapse and anti-incontinence procedures (e.g., laparoscopic supracervical hysterectomy, cystocele repair, rectocele repair or mid-urethral sling procedures) will be performed at the primary surgeon's discretion.

Exclusion criteria

* Inability to comprehend written and/or spoken English * Inability to provide informed consent * Medical illness precluding laparoscopy * Need for concomitant surgeries not related to pelvic organ prolapse or incontinence * Sacrocolpoperineopexy

Design outcomes

Primary

MeasureTime frame
Total Suturing Time for Mesh Placement = Time From Insertion of Y Mesh or First Flat Mesh Arm Into Pelvis to Last Sacral Suture Placedone day intraoperative
Total OR Time = Operating Room Time of Entry and Exitone day intraoperative

Secondary

MeasureTime frameDescription
Postoperative Mean Difference UDI at 24 Months24 monthsMean difference between baseline (pre-procedure) and 24-months post-procedure. The UDI is a six-item measure from the PFDI-20 which measures 6 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms).
Postoperative Subjective Recurrence at 24 Months24 monthsSubjective Recurrence was defined as patients who complained of vaginal bulge symptoms (Question #3 on the PFDI-20).
Post-operative Mean Difference POPDI at 24 Months24 monthsMean difference between baseline (pre-procedure) and 24-months post-procedure. The POPDI is a six-item measure from the PFDI-20 which measures 6 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms).
Reported Mesh Erosion at 24 Months24 monthsMesh Erosion was defined as presence of eroded mesh in the vagina on examination postoperatively up to 24-months after surgery.
Postoperative Objective Recurrence at 24 Months24 monthsObjective Recurrence
Postoperative Mean Difference CRADI at 24 Months24 monthsMean difference between baseline (pre-procedure) and 24-months post-procedure. The CRADI is a eight-item measure from the PFDI-20 which measures 8 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms).

Countries

United States

Participant flow

Participants by arm

ArmCount
Cololast, Inc. Restorell Y Mesh
Y mesh Y mesh: Y mesh
30
Coloplast, Inc. Restorelle Dual Flat Mesh
Dual flat mesh Dual flat mesh: Dual flat mesh
29
Total59

Baseline characteristics

CharacteristicTotalColoplast, Inc. Restorelle Dual Flat MeshCololast, Inc. Restorell Y Mesh
Age, Continuous61 years
STANDARD_DEVIATION 8
62.4 years
STANDARD_DEVIATION 8.1
60.3 years
STANDARD_DEVIATION 7.3
Body Mass Index (BMI)28.5 kg/m^2
STANDARD_DEVIATION 3.9
28.2 kg/m^2
STANDARD_DEVIATION 4.2
28.9 kg/m^2
STANDARD_DEVIATION 3.5
Parity3 pregnancies2 pregnancies3 pregnancies
Prior prolapse surgery30 Participants15 Participants15 Participants
Prolapse Stage 10 Participants0 Participants0 Participants
Prolapse Stage 219 Participants10 Participants9 Participants
Prolapse Stage 337 Participants17 Participants20 Participants
Prolapse Stage 43 Participants2 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
4 Participants2 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
55 Participants27 Participants28 Participants
Sex: Female, Male
Female
59 Participants29 Participants30 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Tobacco use5 Participants3 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 29
other
Total, other adverse events
0 / 300 / 29
serious
Total, serious adverse events
0 / 300 / 29

Outcome results

Primary

Total OR Time = Operating Room Time of Entry and Exit

Time frame: one day intraoperative

ArmMeasureValue (MEAN)Dispersion
Coloplast, Inc. Restorelle Y MeshTotal OR Time = Operating Room Time of Entry and Exit204.2 minutesStandard Deviation 52.8
Coloplast, Inc. Restorelle Dual Flat MeshTotal OR Time = Operating Room Time of Entry and Exit204.5 minutesStandard Deviation 43.7
Primary

Total Suturing Time for Mesh Placement = Time From Insertion of Y Mesh or First Flat Mesh Arm Into Pelvis to Last Sacral Suture Placed

Time frame: one day intraoperative

ArmMeasureValue (MEAN)Dispersion
Coloplast, Inc. Restorelle Y MeshTotal Suturing Time for Mesh Placement = Time From Insertion of Y Mesh or First Flat Mesh Arm Into Pelvis to Last Sacral Suture Placed46 minutesStandard Deviation 14.7
Coloplast, Inc. Restorelle Dual Flat MeshTotal Suturing Time for Mesh Placement = Time From Insertion of Y Mesh or First Flat Mesh Arm Into Pelvis to Last Sacral Suture Placed46.3 minutesStandard Deviation 12.3
Secondary

Postoperative Mean Difference CRADI at 24 Months

Mean difference between baseline (pre-procedure) and 24-months post-procedure. The CRADI is a eight-item measure from the PFDI-20 which measures 8 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms).

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Coloplast, Inc. Restorelle Y MeshPostoperative Mean Difference CRADI at 24 Months-24.2 score on a scaleStandard Deviation 20.6
Coloplast, Inc. Restorelle Dual Flat MeshPostoperative Mean Difference CRADI at 24 Months-20.2 score on a scaleStandard Deviation 16.1
Secondary

Post-operative Mean Difference POPDI at 24 Months

Mean difference between baseline (pre-procedure) and 24-months post-procedure. The POPDI is a six-item measure from the PFDI-20 which measures 6 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms).

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Coloplast, Inc. Restorelle Y MeshPost-operative Mean Difference POPDI at 24 Months-32.5 score on a scaleStandard Deviation 24.1
Coloplast, Inc. Restorelle Dual Flat MeshPost-operative Mean Difference POPDI at 24 Months-40.7 score on a scaleStandard Deviation 26.9
Secondary

Postoperative Mean Difference UDI at 24 Months

Mean difference between baseline (pre-procedure) and 24-months post-procedure. The UDI is a six-item measure from the PFDI-20 which measures 6 different pelvic organ prolapse symptoms and degree of bother. The scale exists from 0-100 (0=no symptoms, 100=worse symptoms).

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Coloplast, Inc. Restorelle Y MeshPostoperative Mean Difference UDI at 24 Months-39.0 score on a scaleStandard Deviation 27
Coloplast, Inc. Restorelle Dual Flat MeshPostoperative Mean Difference UDI at 24 Months-33.2 score on a scaleStandard Deviation 18.9
Secondary

Postoperative Objective Recurrence at 24 Months

Objective Recurrence

Time frame: 24 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Coloplast, Inc. Restorelle Y MeshPostoperative Objective Recurrence at 24 Months5 Participants
Coloplast, Inc. Restorelle Dual Flat MeshPostoperative Objective Recurrence at 24 Months4 Participants
Secondary

Postoperative Subjective Recurrence at 24 Months

Subjective Recurrence was defined as patients who complained of vaginal bulge symptoms (Question #3 on the PFDI-20).

Time frame: 24 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Coloplast, Inc. Restorelle Y MeshPostoperative Subjective Recurrence at 24 Months2 Participants
Coloplast, Inc. Restorelle Dual Flat MeshPostoperative Subjective Recurrence at 24 Months2 Participants
Secondary

Reported Mesh Erosion at 24 Months

Mesh Erosion was defined as presence of eroded mesh in the vagina on examination postoperatively up to 24-months after surgery.

Time frame: 24 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Coloplast, Inc. Restorelle Y MeshReported Mesh Erosion at 24 Months0 Participants
Coloplast, Inc. Restorelle Dual Flat MeshReported Mesh Erosion at 24 Months0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026